Gerben R. Borst - Concepedia

Author

Gerben R. Borst

The Netherlands Cancer Institute ORCID

Also Known As

G R Borst, G. Borst, G. R. Borst, G.R. Borst, Gerben Borst, Gerben R Borst, Gerben R. Borst, Gerben Roelof Borst

131

Publications

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute University of Manchester The Maria Sklodowska-Curie National Research Institute of Oncology Erasmus MC Cancer Institute

About

Gerben R. Borst is an author at The Netherlands Cancer Institute specializing in radiation oncology, medicine, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	906
2	Health Sciences	10	10	861
3	Engineering	1	1	125
4	Nursing	1	1	41
5	Social Sciences	1	1	41

Gerben R. Borst

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancer Gerben R. Borst, J. Belderbos, Ronald Boellaard, European Journal of Cancer Fdg UptakeAdvanced Lung DiseasePrognostic FactorMedicineBronchial Neoplasm	2005	184
Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy Gerben R. Borst, Masayori Ishikawa, Jasper Nijkamp, Radiotherapy and Oncology Radiation MedicineHealth SciencesRadiation TherapyPneumothoraxMultiple Pulmonary Nodule	2009	142
Clinical Results of Image-Guided Deep Inspiration Breath Hold Breast Irradiation Gerben R. Borst, Jan‐Jakob Sonke, Suzanne den Hollander, International Journal of Radiation OncologyBiologyPhysics Clinical ResultsRadiation MedicineMedical ImagingRadiation TherapyMedicine	2010	140
Kilo-Voltage Cone-Beam Computed Tomography Setup Measurements for Lung Cancer Patients; First Clinical Results and Comparison With Electronic Portal-Imaging Device Gerben R. Borst, Jan‐Jakob Sonke, A. Betgen, International Journal of Radiation OncologyBiologyPhysics Computed TomographyFirst Clinical ResultsEngineeringMedical ImagingBiomedical Imaging	2007	125
Pulmonary function changes after radiotherapy in non–small-cell lung cancer patients with long-term disease-free survival Gerben R. Borst, Katrien De Jaeger, J. Belderbos, International Journal of Radiation OncologyBiologyPhysics Health SciencesAdvanced Lung DiseaseMedicineMultiple Pulmonary NoduleLong-term Disease-free Survival	2005	95
CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma Luuk van Hooren, Shanna M. Handgraaf, Daan J. Kloosterman, Nature Cancer	2023	86
Radiation Pneumonitis After Hypofractionated Radiotherapy: Evaluation of the LQ(L) Model and Different Dose Parameters Gerben R. Borst, Masayori Ishikawa, Jasper Nijkamp, International Journal of Radiation OncologyBiologyPhysics Different Dose ParametersHealth SciencesRadiation TherapyTreatment VerificationHypofractionated Radiotherapy	2010	67
Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis Zafer Koçak, Gerben R. Borst, Jing Zeng, International Journal of Radiation OncologyBiologyPhysics DiagnosisRadiation DoseProspective AssessmentRadiation Therapy PlanningMedicine	2006	64
A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities Rick L. Haas, Hans Gelderblom, Stefan Sleijfer, Acta Oncologica	2015	64
Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors Marco Barazas, Alessia Gasparini, Yike Huang, Cancer Research	2018	60

Page 1